ABCF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.36686234447825E-12 |
Normal-vs-Stage2 |
4.96769958502341E-10 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.79878334449768E-12 |
Stage1-vs-Stage2 |
3.510100E-02 |
Stage1-vs-Stage3 |
1.038160E-03 |
Stage1-vs-Stage4 |
7.186400E-02 |
Stage2-vs-Stage3 |
9.618600E-01 |
Stage2-vs-Stage4 |
5.691600E-01 |
Stage3-vs-Stage4 |
3.954600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
4.75119999998608E-06 |
Normal-vs-Asian |
1.250290E-02 |
Caucasian-vs-AfricanAmerican |
2.588100E-02 |
Caucasian-vs-Asian |
3.978200E-01 |
AfricanAmerican-vs-Asian |
9.659000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
7.29490001738498E-09 |
Male-vs-Female |
1.0358000002153E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.05440001174628E-09 |
Normal-vs-Age(41-60Yrs) |
1.63002944475465E-12 |
Normal-vs-Age(61-80Yrs) |
1.63091762317435E-12 |
Normal-vs-Age(81-100Yrs) |
9.38119999460696E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.402360E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.757610E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.114200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.912200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.860800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.251000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.749600E-02 |
Normal-vs-Grade 2 |
3.25317550675663E-12 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62680979798324E-12 |
Grade 1-vs-Grade 2 |
1.096560E-01 |
Grade 1-vs-Grade 3 |
9.064300E-03 |
Grade 1-vs-Grade 4 |
4.038000E-03 |
Grade 2-vs-Grade 3 |
1.449920E-02 |
Grade 2-vs-Grade 4 |
1.676490E-02 |
Grade 3-vs-Grade 4 |
5.029000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.89609497178867E-11 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
2.26190000000015E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.53210777398272E-14 |
Normal-vs-N1 |
1.69529999999307E-05 |
N0-vs-N1 |
6.098400E-01 |
|
|